Changchun GeneScience Pharmaceutical Co., Ltd.
Registry sponsor category
Industry
- Other names
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Company name
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (114)
- A Bioavailability Study of GS1-144 Tablets in Healthy Postmenopausal Women
- A Bioavailability Study of Two Different PEG-rhGH Preparations.
- A Bioequivalence Study of Two Different Dosage Form of Genakumab
- A Bioequivalence Study of Two Different PEG-rhGH Preparations
- A Bioequivalence Study of Two Different PEG-rhGH Preparations.
- A Bioequivalence Study of Two Different Processes of PEG-rhGH Preparations
- A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)
- A Clinical Study to Evaluate the Absorption, Metabolism, and Excretion of Oral [14C]GS1-144 in Healthy Postmenopausal Female Participants
- A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations
- A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH Preparations
- A First-in-Human Safety and Pharmacokinetic Trial of GenSci142 Administered as Single Ascending Doses in Healthy Chinese Women
- A Non-inferiority Phase 2 Study to Evaluate the Safety and Efficacy of PEG-rhGH in the Treatment of AGHD
- A Phase 2, Randomized, Placebo-controlled, Double-blind Study of EG017 in Female Patients With Stress Urinary Incontinence
- A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Oral Dose Escalation of GS1-144 Tablets and the Effects of Food on the Pharmacokinetics of GS1-144 in a Chinese Population
- A Phase I First-in-Human Study of GenSci128 in Patients With Solid Tumors Harboring a TP53 Y220C Mutation
- A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics
- A Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients With Moderate to Severe Endometriosis-Associated Pain
- A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate Tablets
- A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in Patients With Cancer Cachexia
- A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease